Fortress Biotech, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-66.9M | $-55.1M | $-48.4M | $-20.4M | $-37.2M | $-27.6M | $-36.4M | $-10.0M |
| Depreciation & Amortization | $1.2M | $944.0K | $26.0K | $23.0K | $17.0K | — | — | — |
| Depreciation | $726.0K | $400.0K | $26.0K | $23.0K | $17.0K | $3.0K | $22.0K | $5.0K |
| Amortization | $1.7M | $0 | $0 | — | — | — | — | — |
| Stock-Based Compensation | $13.4M | $12.1M | $14.3M | $5.5M | $5.9M | $3.6M | — | — |
| Net Cash from Operating Activities | $-81.3M | $-45.8M | $-20.4M | $-16.3M | $-29.6M | $-23.2M | $-11.0M | $-5.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $648.0K | $6.4M | $283.0K | $0 | $40.0K | $54.0K | $0 | — |
| Business Acquisitions | $4.6M | $4.6M | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-40.2M | $-6.1M | $7.9M | — | $-188.0K | $-279.0K | $-3.8M | $-13.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $150.4M | $42.9M | $60.9M | — | $89.2M | $40.5M | $23.1M | $19.0M |
| Net Change in Cash | $28.9M | $-9.9M | $48.4M | $-49.8M | $59.3M | $17.0M | $8.3M | $13.4M |
| Free Cash Flow | $-82.0M | $-52.2M | $-20.7M | $-16.3M | $-29.7M | $-23.2M | $-11.0M | — |